Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19 ERVK-25	9.61e-08	37	123	6	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19 ERVK-25	1.14e-07	38	123	6	GO:0070001
GeneOntologyMolecularFunction	calmodulin binding	MAP2 MYO7A MYO1B GRM4 ACE AKAP12 ITPKB AEBP1	9.07e-05	230	123	8	GO:0005516
GeneOntologyMolecularFunction	allyl-alcohol dehydrogenase activity	AKR1B10 AKR1B1	2.24e-04	4	123	2	GO:0047655
GeneOntologyMolecularFunction	cytoskeletal regulatory protein binding	CTTNBP2 MAP2	3.72e-04	5	123	2	GO:0005519
GeneOntologyMolecularFunction	structural molecule activity	ERVK-6 MXRA5 COL12A1 MAP2 ERVK-21 ERVK-9 ODF2 NPHP4 DST SHANK2 HMCN1 AEBP1 ERVK-8 ERVK-19 ERVK-25	3.85e-04	891	123	15	GO:0005198
GeneOntologyMolecularFunction	histone H3K9me2/H3K9me3 demethylase activity	KDM1A KDM4B	5.55e-04	6	123	2	GO:0140684
GeneOntologyMolecularFunction	peptidase activity	ERVK-6 PRSS57 ERVK-21 ERVK-9 ACE AEBP1 ERVK-8 PAN2 ADAMTS18 OTUD4 ERVK-19 ERVK-25	7.22e-04	654	123	12	GO:0008233
GeneOntologyBiologicalProcess	cell-cell fusion	ERVK-6 ERVK-21 ERVK-9 NEO1 NFATC2 ERVK-8 ERVK-19 ERVS71-1	4.44e-08	85	124	8	GO:0140253
GeneOntologyBiologicalProcess	syncytium formation by plasma membrane fusion	ERVK-6 ERVK-21 ERVK-9 NEO1 NFATC2 ERVK-8 ERVK-19 ERVS71-1	4.44e-08	85	124	8	GO:0000768
GeneOntologyBiologicalProcess	syncytium formation	ERVK-6 ERVK-21 ERVK-9 NEO1 NFATC2 ERVK-8 ERVK-19 ERVS71-1	6.39e-08	89	124	8	GO:0006949
Domain	IGc2	PRTG MXRA5 DSCAM L1CAM FGFRL1 SIGLEC5 LRRC4 IGDCC4 IGSF10 NEO1 HMCN1 IGSF1	3.13e-08	235	118	12	SM00408
Domain	Ig_sub2	PRTG MXRA5 DSCAM L1CAM FGFRL1 SIGLEC5 LRRC4 IGDCC4 IGSF10 NEO1 HMCN1 IGSF1	3.13e-08	235	118	12	IPR003598
Domain	Ig-like_fold	PRTG MXRA5 COL12A1 DSCAM L1CAM FGFRL1 SIGLEC5 LRRC4 IGDCC4 IGSF10 FNDC1 NEO1 SHANK2 HMCN1 NFATC1 PTPRM NFATC2 CRTAM IGSF1	9.10e-08	706	118	19	IPR013783
Domain	-	PRTG MXRA5 COL12A1 DSCAM L1CAM FGFRL1 SIGLEC5 LRRC4 IGDCC4 IGSF10 FNDC1 NEO1 HMCN1 NFATC1 PTPRM NFATC2 CRTAM IGSF1	1.81e-07	663	118	18	2.60.40.10
Domain	Ig_I-set	PRTG MXRA5 DSCAM L1CAM FGFRL1 LRRC4 IGDCC4 IGSF10 NEO1 HMCN1	3.53e-07	190	118	10	IPR013098
Domain	I-set	PRTG MXRA5 DSCAM L1CAM FGFRL1 LRRC4 IGDCC4 IGSF10 NEO1 HMCN1	3.53e-07	190	118	10	PF07679
Domain	IG	PRTG MXRA5 DSCAM L1CAM FGFRL1 SIGLEC5 LRRC4 IGDCC4 IGSF10 NEO1 HMCN1 PTPRM CRTAM IGSF1	4.37e-07	421	118	14	SM00409
Domain	Ig_sub	PRTG MXRA5 DSCAM L1CAM FGFRL1 SIGLEC5 LRRC4 IGDCC4 IGSF10 NEO1 HMCN1 PTPRM CRTAM IGSF1	4.37e-07	421	118	14	IPR003599
Domain	IG_LIKE	PRTG MXRA5 DSCAM L1CAM FGFRL1 SIGLEC5 LRRC4 IGDCC4 IGSF10 NEO1 HMCN1 PTPRM CRTAM IGSF1	2.68e-06	491	118	14	PS50835
Domain	Ig-like_dom	PRTG MXRA5 DSCAM L1CAM FGFRL1 SIGLEC5 LRRC4 IGDCC4 IGSF10 NEO1 HMCN1 PTPRM CRTAM IGSF1	3.55e-06	503	118	14	IPR007110
Domain	fn3	PRTG COL12A1 DSCAM L1CAM IGDCC4 FNDC1 NEO1 PTPRM	8.78e-06	162	118	8	PF00041
Domain	FN3	PRTG COL12A1 DSCAM L1CAM IGDCC4 FNDC1 NEO1 PTPRM	2.30e-05	185	118	8	SM00060
Domain	FN3	PRTG COL12A1 DSCAM L1CAM IGDCC4 FNDC1 NEO1 PTPRM	3.88e-05	199	118	8	PS50853
Domain	FN3_dom	PRTG COL12A1 DSCAM L1CAM IGDCC4 FNDC1 NEO1 PTPRM	5.49e-05	209	118	8	IPR003961
Domain	ig	DSCAM FGFRL1 SIGLEC5 LRRC4 HMCN1 PTPRM IGSF1	2.06e-04	190	118	7	PF00047
Domain	Immunoglobulin	DSCAM FGFRL1 SIGLEC5 LRRC4 HMCN1 PTPRM IGSF1	2.06e-04	190	118	7	IPR013151
Domain	P5-ATPase	ATP13A4 ATP13A5	2.36e-04	4	118	2	PF12409
Domain	PDZ	INTU FRMPD2 SHANK2 PDZRN3 AHNAK2 PDZD2	3.56e-04	148	118	6	SM00228
Domain	-	INTU FRMPD2 SHANK2 PDZRN3 AHNAK2 PDZD2	3.82e-04	150	118	6	2.30.42.10
Domain	P-type_TPase_V	ATP13A4 ATP13A5	3.91e-04	5	118	2	IPR006544
Domain	NFAT	NFATC1 NFATC2	3.91e-04	5	118	2	IPR008366
Domain	PDZ	INTU FRMPD2 SHANK2 PDZRN3 AHNAK2 PDZD2	3.96e-04	151	118	6	PS50106
Domain	PDZ	INTU FRMPD2 SHANK2 PDZRN3 AHNAK2 PDZD2	4.10e-04	152	118	6	IPR001478
Domain	Kelch	KLHL1 KLHL31 KLHL30 KLHDC8A	4.94e-04	58	118	4	SM00612
Domain	Kelch_1	KLHL1 KLHL31 KLHL30 KLHDC8A	1.01e-03	70	118	4	PF01344
Domain	Kelch_1	KLHL1 KLHL31 KLHL30 KLHDC8A	1.01e-03	70	118	4	IPR006652
Domain	ALDOKETO_REDUCTASE_1	AKR1B10 AKR1B1	1.72e-03	10	118	2	PS00798
Domain	RHD_dimer	NFATC1 NFATC2	1.72e-03	10	118	2	IPR032397
Domain	RHD_dimer	NFATC1 NFATC2	1.72e-03	10	118	2	PF16179
Domain	REL_1	NFATC1 NFATC2	1.72e-03	10	118	2	PS01204
Domain	ALDOKETO_REDUCTASE_2	AKR1B10 AKR1B1	1.72e-03	10	118	2	PS00062
Domain	ALDOKETO_REDUCTASE_3	AKR1B10 AKR1B1	1.72e-03	10	118	2	PS00063
Domain	-	NFATC1 NFATC2	1.72e-03	10	118	2	2.60.40.340
Domain	NFkB/Dor	NFATC1 NFATC2	1.72e-03	10	118	2	IPR000451
Domain	Aldo/ket_reductase_CS	AKR1B10 AKR1B1	1.72e-03	10	118	2	IPR018170
Domain	RHD_DNA_bind_dom	NFATC1 NFATC2	1.72e-03	10	118	2	IPR011539
Domain	Aldo/keto_reductase	AKR1B10 AKR1B1	1.72e-03	10	118	2	IPR020471
Domain	RHD_DNA_bind	NFATC1 NFATC2	1.72e-03	10	118	2	PF00554
Domain	REL_2	NFATC1 NFATC2	1.72e-03	10	118	2	PS50254
Domain	PDZ	FRMPD2 SHANK2 PDZRN3 AHNAK2 PDZD2	2.02e-03	141	118	5	PF00595
Domain	EXOIII	ERI2 PAN2	3.43e-03	14	118	2	SM00479
Domain	Exonuclease_RNaseT/DNA_pol3	ERI2 PAN2	3.43e-03	14	118	2	IPR013520
Domain	RNase_T	ERI2 PAN2	3.43e-03	14	118	2	PF00929
Domain	-	MYO7A FRMPD2 ACBD3	3.67e-03	49	118	3	1.20.80.10
Domain	FERM/acyl-CoA-bd_prot_3-hlx	MYO7A FRMPD2 ACBD3	3.88e-03	50	118	3	IPR014352
Domain	-	AKR1B10 AKR1B1	4.48e-03	16	118	2	3.20.20.100
Domain	p53-like_TF_DNA-bd	NFATC1 NFATC2 FUT3	4.58e-03	53	118	3	IPR008967
Domain	NADP_OxRdtase_dom	AKR1B10 AKR1B1	5.06e-03	17	118	2	IPR023210
Domain	Aldo_ket_red	AKR1B10 AKR1B1	5.06e-03	17	118	2	PF00248
Domain	Aldo/ket_red/Kv-b	AKR1B10 AKR1B1	5.06e-03	17	118	2	IPR001395
Domain	Cation_ATPase_N	ATP13A4 ATP13A5	5.67e-03	18	118	2	PF00690
Domain	Cation_ATPase_N	ATP13A4 ATP13A5	5.67e-03	18	118	2	SM00831
Domain	Gal_Oxase/kelch_b-propeller	KLHL1 KLHL31 KLHDC8A	6.18e-03	59	118	3	IPR011043
Domain	ATPase_P-typ_cation-transptr_N	ATP13A4 ATP13A5	6.31e-03	19	118	2	IPR004014
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19 ERVS71-1	1.82e-12	12	126	6	14557543
Pubmed	Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins.	ERVK-6 ERVK-21 ERVK-19 ERVS71-1	3.39e-08	10	126	4	12970426
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19 ERVK-25 ERVS71-1	5.46e-08	94	126	7	21542922
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	PRTG DSCAM LRRC4 IGDCC4 IGSF10 HMCN1 PTPRM IGSF1	1.47e-07	162	126	8	25826454
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-21 ERVK-19	4.62e-07	5	126	3	12629516
Pubmed	Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.	ERVK-6 ERVK-9 ERVK-19	9.21e-07	6	126	3	15063128
Pubmed	Draxin from neocortical neurons controls the guidance of thalamocortical projections into the neocortex.	DSCAM MAP2 L1CAM NEO1	1.38e-06	23	126	4	26659141
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	NCOA6 LIMA1 PPM1D RTTN MUC16 CRACD HYDIN	3.05e-06	170	126	7	23314748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMG1 NCOA6 ERBB2 ERI2 DST CAPRIN2 PAN2 IGSF1 KDM1A KDM4B PPP6R3	3.83e-06	529	126	11	14621295
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	NCOA6 ATP13A5 DST RESF1 AHNAK2 PDZD2	6.03e-06	123	126	6	26912792
Pubmed	Endocardial Hippo signaling regulates myocardial growth and cardiogenesis.	ERBB2 WWTR1 NFATC1	7.50e-06	11	126	3	29727635
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ATXN7L1 DST RESF1 SCAPER IGSF1 PDZD2	8.29e-06	130	126	6	12421765
Pubmed	NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.	NFATC1 NFATC2	1.30e-05	2	126	2	26483414
Pubmed	Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism.	ACE F5	1.30e-05	2	126	2	11122103
Pubmed	Accumulation of NFAT mediates IL-2 expression in memory, but not naïve, CD4+ T cells.	NFATC1 NFATC2	1.30e-05	2	126	2	17438271
Pubmed	Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians.	AKR1B10 AKR1B1	1.30e-05	2	126	2	15745835
Pubmed	NFAT1 and NFAT2 Differentially Regulate CTL Differentiation Upon Acute Viral Infection.	NFATC1 NFATC2	1.30e-05	2	126	2	30828328
Pubmed	Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke.	ACE F5	1.30e-05	2	126	2	11596779
Pubmed	Characterization of a novel cation transporter ATPase gene (ATP13A4) interrupted by 3q25-q29 inversion in an individual with language delay.	ATP13A4 ATP13A5	1.30e-05	2	126	2	15925480
Pubmed	ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.	ERBB2 GLS	1.30e-05	2	126	2	24122876
Pubmed	Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks.	AKR1B10 AKR1B1	1.30e-05	2	126	2	33945128
Pubmed	Membrane microdomain organization, calcium signal, and NFAT activation as an important axis in polarized Th cell function.	NFATC1 NFATC2	1.30e-05	2	126	2	23184643
Pubmed	Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry.	AKR1B10 AKR1B1	1.30e-05	2	126	2	28003428
Pubmed	Decreased levels of AKR1B1 and AKR1B10 in cancerous endometrium compared to adjacent non-cancerous tissue.	AKR1B10 AKR1B1	1.30e-05	2	126	2	23146748
Pubmed	Nuclear factor of activated T cells 1 and 2 are required for vertebral homeostasis.	NFATC1 NFATC2	1.30e-05	2	126	2	32329053
Pubmed	NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription.	NFATC1 NFATC2	1.30e-05	2	126	2	12355451
Pubmed	The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.	ACE F5	1.30e-05	2	126	2	20853144
Pubmed	Regulation of the murine Nfatc1 gene by NFATc2.	NFATC1 NFATC2	1.30e-05	2	126	2	11786533
Pubmed	A common variant of RIP3 promoter region is associated with poor prognosis in heart failure patients by influencing SOX17 binding.	RIPK3 SOX17	1.30e-05	2	126	2	31148336
Pubmed	NFATc1 and NFATc2 together control both T and B cell activation and differentiation.	NFATC1 NFATC2	1.30e-05	2	126	2	11163226
Pubmed	An enhanced immune response in mice lacking the transcription factor NFAT1.	NFATC1 NFATC2	1.30e-05	2	126	2	8629027
Pubmed	Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells.	NFATC1 NFATC2	1.30e-05	2	126	2	9845362
Pubmed	Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism.	AKR1B10 AKR1B1	1.30e-05	2	126	2	29617059
Pubmed	The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.	NFATC1 NFATC2	1.30e-05	2	126	2	25680272
Pubmed	Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).	AKR1B10 AKR1B1	1.30e-05	2	126	2	24100137
Pubmed	Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.	NFATC1 NFATC2	1.30e-05	2	126	2	25583478
Pubmed	NFATc1 and NFATc2 repress spontaneous osteoarthritis.	NFATC1 NFATC2	1.30e-05	2	126	2	24248346
Pubmed	Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.	NFATC1 NFATC2	1.30e-05	2	126	2	37933452
Pubmed	Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.	AKR1B10 AKR1B1	1.30e-05	2	126	2	28929377
Pubmed	Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.	ERVK-6 ERVK-19	1.30e-05	2	126	2	9060628
Pubmed	Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.	ERVK-6 ERVK-19	1.30e-05	2	126	2	9460924
Pubmed	Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway.	AKR1B10 AKR1B1	1.30e-05	2	126	2	32628753
Pubmed	Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism.	AKR1B10 AKR1B1	1.30e-05	2	126	2	12732097
Pubmed	Cloning and chromosomal localization of the human and murine genes for the T-cell transcription factors NFATc and NFATp.	NFATC1 NFATC2	1.30e-05	2	126	2	7842733
Pubmed	NF-AT components define a family of transcription factors targeted in T-cell activation.	NFATC1 NFATC2	1.30e-05	2	126	2	8202141
Pubmed	Retinoic acid-induced CCR9 expression requires transient TCR stimulation and cooperativity between NFATc2 and the retinoic acid receptor/retinoid X receptor complex.	NFATC1 NFATC2	1.30e-05	2	126	2	21148038
Pubmed	Identification and characterization of a novel human aldose reductase-like gene.	AKR1B10 AKR1B1	1.30e-05	2	126	2	9565553
Pubmed	The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty.	ACE F5	1.30e-05	2	126	2	11311153
Pubmed	Cutting Edge: NFAT Transcription Factors Promote the Generation of Follicular Helper T Cells in Response to Acute Viral Infection.	NFATC1 NFATC2	1.30e-05	2	126	2	26851216
Pubmed	Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors.	NFATC1 NFATC2	1.30e-05	2	126	2	18809576
Pubmed	Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds.	AKR1B10 AKR1B1	1.30e-05	2	126	2	21329684
Pubmed	Reciprocal NFAT1 and NFAT2 nuclear localization in CD8+ anergic T cells is regulated by suboptimal calcium signaling.	NFATC1 NFATC2	1.30e-05	2	126	2	17785810
Pubmed	Microglial phenotype is regulated by activity of the transcription factor, NFAT (nuclear factor of activated T cells).	NFATC1 NFATC2	1.30e-05	2	126	2	20631193
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NCOA6 ERBB2 LIMA1 RAPH1 MAP2 WWTR1 PAK6 ITPKB DST RESF1 PLK4 AHNAK2 DOP1B	1.56e-05	861	126	13	36931259
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CEP290 ODF2 F5 KAT7 DST DZIP3 SGF29 AKR1B1 CDCA5 KDM1A KDM4B	2.43e-05	645	126	11	25281560
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-21 ERVK-9 ERVK-25	3.64e-05	18	126	3	18664271
Pubmed	Myosin VIIA is specifically associated with calmodulin and microtubule-associated protein-2B (MAP-2B).	MAP2 MYO7A	3.90e-05	3	126	2	11171103
Pubmed	NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.	NFATC1 NFATC2	3.90e-05	3	126	2	34234374
Pubmed	Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer.	ERBB2 MUC16	3.90e-05	3	126	2	17852076
Pubmed	Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction.	NCOA6 MAP2	3.90e-05	3	126	2	12556486
Pubmed	Selective activation of NFAT by promyelocytic leukemia protein.	NFATC1 NFATC2	3.90e-05	3	126	2	18246125
Pubmed	Autoamplification of NFATc1 expression determines its essential role in bone homeostasis.	NFATC1 NFATC2	3.90e-05	3	126	2	16275763
Pubmed	Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells.	NFATC1 NFATC2	3.90e-05	3	126	2	12594266
Pubmed	Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.	AKR1B10 AKR1B1	3.90e-05	3	126	2	17381426
Pubmed	Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.	ERVK-6 ERVK-9	3.90e-05	3	126	2	9971820
Pubmed	NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.	NFATC1 NFATC2	3.90e-05	3	126	2	19900447
Pubmed	Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients.	NFATC1 NFATC2	3.90e-05	3	126	2	17082665
Pubmed	Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines.	NFATC1 NFATC2	3.90e-05	3	126	2	17082579
Pubmed	NFATc1 controls the cytotoxicity of CD8+ T cells.	NFATC1 NFATC2	3.90e-05	3	126	2	28894104
Pubmed	An innate cell-mediated, murine ulcerative colitis-like syndrome in the absence of nuclear factor of activated T cells.	NFATC1 NFATC2	3.90e-05	3	126	2	15057750
Pubmed	Identification of a phosphorylation site on Ulk1 required for genotoxic stress-induced alternative autophagy.	RIPK3 PPM1D	3.90e-05	3	126	2	32273498
Pubmed	Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2.	NFATC1 NFATC2	3.90e-05	3	126	2	15632146
Pubmed	Interaction between very-KIND Ras guanine exchange factor and microtubule-associated protein 2, and its role in dendrite growth--structure and function of the second kinase noncatalytic C-lobe domain.	MAP2 FRMPD2	3.90e-05	3	126	2	21385318
Pubmed	Synthesis of disialyl Lewis a (Le(a)) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of alpha-series gangliosides.	ST6GALNAC6 FUT3	3.90e-05	3	126	2	12668675
Pubmed	Rapid and Efficient Gene Editing for Direct Transplantation of Naive Murine Cas9+ T Cells.	NFATC1 NFATC2	3.90e-05	3	126	2	34367143
Pubmed	Molecular cloning and functional characterization of murine cDNA encoding transcription factor NFATc.	NFATC1 NFATC2	3.90e-05	3	126	2	9388475
Pubmed	NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.	NFATC1 NFATC2	3.90e-05	3	126	2	25630465
Pubmed	NFAT1 and NFAT2 differentially regulate IL-17A expression in human T cells.	NFATC1 NFATC2	3.90e-05	3	126	2	22627363
Pubmed	The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism.	ACE F5	3.90e-05	3	126	2	14597977
Pubmed	NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity.	NFATC1 NFATC2	3.90e-05	3	126	2	7650004
Pubmed	Differential contribution of NFATc2 and NFATc1 to TNF-alpha gene expression in T cells.	NFATC1 NFATC2	3.90e-05	3	126	2	18097033
Pubmed	Overestimation of genetic risks owing to small sample sizes in cardiovascular studies.	ACE F5	3.90e-05	3	126	2	12791034
Pubmed	Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension.	ACE EDNRB	3.90e-05	3	126	2	18758497
Pubmed	Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.	ERVK-6 ERVK-19	3.90e-05	3	126	2	10516026
Pubmed	FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression.	NFATC1 NFATC2	3.90e-05	3	126	2	19564342
Pubmed	Combined effect of Factor V Leiden, MTHFR, and angiotensin-converting enzyme (insertion/deletion) gene mutations in hypertensive adult individuals: a population-based study from Sivas and Canakkale, Turkey.	ACE F5	3.90e-05	3	126	2	21699409
Pubmed	Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact.	ERBB2 MUC16	3.90e-05	3	126	2	19270645
Pubmed	[A study of relationship between oral contraceptives and gene polymorphism and types of stroke].	ACE F5	3.90e-05	3	126	2	11718065
Pubmed	The potency of TCR signaling differentially regulates NFATc/p activity and early IL-4 transcription in naive CD4+ T cells.	NFATC1 NFATC2	3.90e-05	3	126	2	11937535
Pubmed	Regulation of NFAT by poly(ADP-ribose) polymerase activity in T cells.	NFATC1 NFATC2	3.90e-05	3	126	2	18078995
Pubmed	Transcriptional activation of the IL31 gene by NFAT and STAT6.	NFATC1 NFATC2	3.90e-05	3	126	2	22045870
Pubmed	NFAT and Osterix cooperatively regulate bone formation.	NFATC1 NFATC2	3.90e-05	3	126	2	16041384
Pubmed	The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers.	MUC16 GLS	3.90e-05	3	126	2	32698888
Pubmed	The transcription factor NFAT4 is involved in the generation and survival of T cells.	NFATC1 NFATC2	3.90e-05	3	126	2	9768749
Pubmed	Thrombotic gene polymorphisms and postoperative outcome after coronary artery bypass graft surgery.	ACE F5	3.90e-05	3	126	2	21955693
Pubmed	Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer.	ERBB2 MUC16	7.78e-05	4	126	2	14566828
Pubmed	Sequential involvement of NFAT and Egr transcription factors in FasL regulation.	NFATC1 NFATC2	7.78e-05	4	126	2	10755616
Pubmed	Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice.	NFATC1 NFATC2	7.78e-05	4	126	2	25918731
Pubmed	Comment on "constitutive nuclear localization of NFAT in Foxp3(+) regulatory T cells independent of calcineurin activity".	NFATC1 NFATC2	7.78e-05	4	126	2	23125425
Pubmed	L1CAM binds ErbB receptors through Ig-like domains coupling cell adhesion and neuregulin signalling.	ERBB2 L1CAM	7.78e-05	4	126	2	22815787
Cytoband	6q25	FNDC1 ULBP1	4.69e-04	12	124	2	6q25
Cytoband	19p13.3	PRSS57 HSD11B1L HMG20B FUT3 KDM4B	4.80e-04	237	124	5	19p13.3
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PRTG MXRA5 DSCAM L1CAM FGFRL1 LRRC4 IGDCC4 IGSF10 NEO1 HMCN1 PTPRM	1.61e-10	161	82	11	593
GeneFamily	Fibronectin type III domain containing	PRTG COL12A1 DSCAM L1CAM IGDCC4 FNDC1 NEO1 PTPRM	6.46e-07	160	82	8	555
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MAP2 MYO7A AKAP12 ACBD3	8.56e-06	29	82	4	396
GeneFamily	PDZ domain containing	INTU FRMPD2 SHANK2 PDZRN3 AHNAK2 PDZD2	6.62e-05	152	82	6	1220
GeneFamily	Nuclear factors of activated T-cells	NFATC1 NFATC2	2.01e-04	5	82	2	665
GeneFamily	Parkinson disease associated genes\|ATPase orphan transporters	ATP13A4 ATP13A5	2.01e-04	5	82	2	1213
GeneFamily	Immunoglobulin like domain containing	MXRA5 DSCAM IGDCC4 NEO1 PTPRM IGSF1	2.45e-04	193	82	6	594
GeneFamily	Kelch like\|BTB domain containing	KLHL1 KLHL31 KLHL30	9.09e-04	42	82	3	617
GeneFamily	Aldo-keto reductases	AKR1B10 AKR1B1	2.05e-03	15	82	2	399
GeneFamily	Exonucleases	ERI2 PAN2	2.34e-03	16	82	2	544
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM1A KDM4B	5.26e-03	24	82	2	485
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ERBB2 L1CAM SIGLEC5 ACE CRTAM FUT3	8.99e-03	394	82	6	471
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL1	PRTG INTU FRMPD2 IGDCC4 ITPKB FNDC1 NFATC2 KLHDC8A IGSF1 HYDIN	6.09e-06	364	118	10	M39057
Coexpression	NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS	MXRA5 MUC16 FNDC1 HMCN1	9.77e-06	30	118	4	M47990
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2C	ATP13A4 LIMA1 CSMD3 INKA2 EDNRB ITPKB NFATC2 CDCA5 PNOC	1.70e-05	325	118	9	M39053
Coexpression	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	AKAP12 DST RESF1 CAPRIN2 DZIP3 PKN2	2.77e-05	130	118	6	M6590
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ATP13A4 COL12A1 MAP2 MYO1B WWTR1 DST SHANK2 PTPRM PDZD2	8.59e-10	170	119	9	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ATP13A4 ERBB2 COL12A1 DSCAM MAP2 MYO1B FNDC1 DST	3.58e-08	184	119	8	cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ATP13A4 ERBB2 COL12A1 DSCAM MAP2 MYO1B FNDC1 DST	3.58e-08	184	119	8	bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PLAC1 MXRA5 COL12A1 CSMD3 AKAP12 NEO1 KLHDC8A PDZRN3	5.18e-08	193	119	8	cd45118ced91b10baed3b1068d4673ec99824b86
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M\|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.	LIMA1 MAP2 PAK6 INKA2 CRACD DST KLHDC8A PDZRN3	6.56e-08	199	119	8	b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	ATP13A4 COL12A1 MAP2 MYO1B DST SHANK2 PDZD2	4.46e-07	174	119	7	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 MAP2 IGSF10 HMCN1 NFATC1 NFATC2 AEBP1	4.82e-07	176	119	7	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 MAP2 IGSF10 HMCN1 NFATC1 NFATC2 AEBP1	4.82e-07	176	119	7	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DLGAP2 EVC2 COL12A1 FGFRL1 INKA2 FNDC1 AHNAK2	5.20e-07	178	119	7	a55130670aa95a87b833dd3cd2de461d779e4c06
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ATP13A4 COL12A1 MAP2 MYO1B DST SHANK2 PDZD2	6.50e-07	184	119	7	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ATP13A4 COL12A1 MAP2 MYO1B DST SHANK2 PDZD2	6.50e-07	184	119	7	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 MAP2 MYO1B DST SHANK2 PDZD2	6.74e-07	185	119	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 DSCAM MAP2 MYO1B DST SHANK2	6.74e-07	185	119	7	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 MAP2 MYO1B DST SHANK2 PDZD2	7.24e-07	187	119	7	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RAPH1 MYO1B F5 NEURL3 NFATC1 PTPRM AHNAK2	7.51e-07	188	119	7	762b52f21d2bc5409f86746a904c4358490be9c0
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CTTNBP2 CSMD3 IGSF10 DST HMCN1 PKN2 PDZRN3	7.78e-07	189	119	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 MAP2 MYO1B DST SHANK2 PDZD2	7.78e-07	189	119	7	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTTNBP2 SOX17 F5 CRACD HMCN1 AKR1B10 AKR1B1	8.06e-07	190	119	7	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 MAP2 MYO1B DST SHANK2 PDZD2	8.06e-07	190	119	7	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	(4)_Endothelial_cells-(40)_EC-arterial\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	L1CAM WWTR1 ACE ITPKB FNDC1 NFATC2 AHNAK2	8.06e-07	190	119	7	ff774faf3f12759d11e50ed7d189288bb79e22e1
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LIMA1 COL12A1 AKAP12 IGDCC4 IGSF10 FNDC1 PDZRN3	8.64e-07	192	119	7	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MXRA5 COL12A1 CRACD FNDC1 HMCN1 AEBP1 PDZRN3	8.64e-07	192	119	7	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	ILEUM-inflamed-(8)_Smooth_muscle_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MXRA5 COL12A1 EDNRB DST AEBP1 PDZRN3 AHNAK2	8.95e-07	193	119	7	084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MXRA5 COL12A1 CRACD FNDC1 HMCN1 AEBP1 PDZRN3	8.95e-07	193	119	7	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	MXRA5 CRACD FNDC1 DST HMCN1 AEBP1 PDZRN3	9.27e-07	194	119	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LIMA1 RAPH1 L1CAM MYO1B WWTR1 GLS DOP1B	9.27e-07	194	119	7	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LIMA1 RAPH1 L1CAM MYO1B WWTR1 GLS DOP1B	9.27e-07	194	119	7	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 MYO1B AKAP12 EDNRB CRACD DST AEBP1	9.59e-07	195	119	7	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	metastatic_Lymph_Node-Fibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	MXRA5 COL12A1 CRACD FNDC1 HMCN1 AEBP1 PDZRN3	9.92e-07	196	119	7	275e153347caf94edc0c50021bbab49c8696fecb
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	MXRA5 COL12A1 CRACD DST HMCN1 AEBP1 PDZRN3	1.03e-06	197	119	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ATP13A4 PRTG MMS22L MAP2 E2F2 FUT3 PLK4	1.03e-06	197	119	7	49689a03ab31e53386dbe15c77c09ca3a14ebf4e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 MAP2 AKAP12 EDNRB NFATC1 NFATC2 AEBP1	1.03e-06	197	119	7	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MXRA5 COL12A1 MYO1B FNDC1 HMCN1 AEBP1 AHNAK2	1.06e-06	198	119	7	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	MXRA5 COL12A1 MAP2 EDNRB HMCN1 AEBP1 PDZRN3	1.06e-06	198	119	7	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	ILEUM-non-inflamed-(8)_Fibroblasts\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MXRA5 COL12A1 AKAP12 EDNRB FNDC1 DST AEBP1	1.10e-06	199	119	7	d9d7f36b4b5592b7855448730044c90997b55499
ToppCell	(1)_T_cell-(18)_cycling_gd_T\|(1)_T_cell / shred on Cell_type and subtype	PRSS57 E2F2 AKAP12 ADAMTS18 CDCA5 PLK4 ZNF730	1.10e-06	199	119	7	9369d0e4efe809e3e8757294ebebba5a47b30528
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MXRA5 COL12A1 AKAP12 EDNRB FNDC1 DST AEBP1	1.10e-06	199	119	7	6a0df9a2f30480043f9c1d7fbdede17eb0910cac
ToppCell	mLN-T_cell-cycling_gd_T\|mLN / Region, Cell class and subclass	PRSS57 E2F2 ERI2 ADAMTS18 CDCA5 PLK4 ZNF730	1.14e-06	200	119	7	4efeef51f885ee8f6dd3911a536cc49e3c14da98
ToppCell	mLN-(1)_T_cell-(18)_cycling_gd_T\|mLN / shred on region, Cell_type, and subtype	PRSS57 E2F2 ERI2 ADAMTS18 CDCA5 PLK4 ZNF730	1.14e-06	200	119	7	e8a0a88a8344e80783931115bbe6cd5b62a4c1f7
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Artery\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CTTNBP2 F5 DST HMCN1 PTPRM AKR1B10 AKR1B1	1.14e-06	200	119	7	ac9ead34afa14067171833f5c277eaf06db7b02e
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	MXRA5 COL12A1 FNDC1 HMCN1 AEBP1 PDZRN3 RAI2	1.14e-06	200	119	7	ca777a7d001848f6d01c613ff2bda7e4f3e20521
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	CTTNBP2 F5 DST HMCN1 PTPRM AKR1B10 AKR1B1	1.14e-06	200	119	7	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRTG SALL3 MYO1B ITPKB HMCN1 ULBP1	4.27e-06	158	119	6	7960337d87afecf2692ab65e5991f052ceddfacc
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 CTTNBP2 MROH2A ATP13A5 HMCN1 HYDIN	4.59e-06	160	119	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 CTTNBP2 MROH2A ATP13A5 HMCN1 HYDIN	4.59e-06	160	119	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	T_cells-TFH-like_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	EVC2 MYO7A F5 ITPKB NFATC1 PTPRM	5.28e-06	164	119	6	b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM MROH2A ATP13A5 CSMD3 AEBP1 HYDIN	6.28e-06	169	119	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	AT1_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	COL12A1 DSCAM MAP2 MYO1B DST AHNAK2	8.18e-06	177	119	6	3128b8d04687acee1ac4190b2569d6328b98eaf3
ToppCell	facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A ERI2 ST6GALNAC6 ULBP1 CDCA5 PLK4	8.18e-06	177	119	6	8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f
ToppCell	facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A ERI2 ST6GALNAC6 ULBP1 CDCA5 PLK4	8.18e-06	177	119	6	e9d7682517fb30fd2ad535d59779d718a7024c13
ToppCell	Endothelial-Endothelial-C\|Endothelial / shred on cell class and cell subclass (v4)	PLAC1 SOX17 ACE AKAP12 HMCN1 PTPRM	8.18e-06	177	119	6	b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MMS22L MUC16 IGDCC4 AEBP1 PNOC AHNAK2	8.45e-06	178	119	6	c77a1d1a9aef0ab51b4408b9e84f201219788ca2
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATP13A4 DSCAM MAP2 MYO1B SHANK2 PDZD2	8.72e-06	179	119	6	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	AT1_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ATP13A4 ERBB2 COL12A1 MAP2 FNDC1 DST	8.72e-06	179	119	6	1603117b52623663458a977c94bf7f9f6c1114b8
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DLGAP2 MXRA5 EDNRB AEBP1 AKR1B1 PDZD2	8.72e-06	179	119	6	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 COL12A1 IGDCC4 HMCN1 AEBP1 PDZRN3	9.00e-06	180	119	6	935c091bbcd6d10b81dc4731779e5bd98205c99f
ToppCell	5'-Airway_Nasal-Mesenchymal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 COL12A1 IGDCC4 HMCN1 AEBP1 PDZRN3	9.00e-06	180	119	6	3dd384b7f3d9582b8fec9fe05100e466e6218b76
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	MXRA5 COL12A1 FNDC1 HMCN1 AEBP1 PDZRN3	9.29e-06	181	119	6	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS57 TEX14 ERI2 ULBP1 CDCA5 PLK4	9.59e-06	182	119	6	3948422707d6d5e021bcd7158e2eb69143613f62
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS57 TEX14 ERI2 ULBP1 CDCA5 PLK4	9.59e-06	182	119	6	fe46819c153a81911864473badc794f243705f98
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 COL12A1 IGDCC4 HMCN1 AEBP1 PDZRN3	9.89e-06	183	119	6	803376f5260de83c48d4f7301278d078a32b3e6e
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 COL12A1 IGDCC4 HMCN1 AEBP1 PDZRN3	9.89e-06	183	119	6	6d98973098c6d20c5305bce6a83a549a7d8dbfba
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MXRA5 COL12A1 IGDCC4 HMCN1 AEBP1 PDZRN3	9.89e-06	183	119	6	cc7f5a17b40e8d901885174922e5fa8877643071
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	ATP13A4 ERBB2 COL12A1 MAP2 FNDC1 RAI2	9.89e-06	183	119	6	6821dca076318115d360ff426eb1218cfe104063
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 COL12A1 MROH2A CSMD3 HMCN1 HYDIN	1.02e-05	184	119	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 COL12A1 MROH2A CSMD3 HMCN1 HYDIN	1.02e-05	184	119	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 COL12A1 MROH2A CSMD3 HMCN1 HYDIN	1.02e-05	184	119	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 MAP2 MYO1B DST PDZD2	1.02e-05	184	119	6	561592edc3083fad41b91811151b442207c65dd9
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTTNBP2 SOX17 F5 HMCN1 AKR1B10 AKR1B1	1.08e-05	186	119	6	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMA1 MYO7A SIGLEC5 CRACD DST SLC12A7	1.08e-05	186	119	6	f1aa0c58336d23bcbe52a59e7af954d20085bdb6
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL12A1 SOX17 MYO1B ACE HMCN1 PTPRM	1.08e-05	186	119	6	a906020a8df6fcca474b278f746c553b177a56b4
ToppCell	droplet-Lung-nan-21m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIMA1 MYO7A SIGLEC5 CRACD DST SLC12A7	1.08e-05	186	119	6	8f77e552e613b6e124443c7f6ef5c1316a5ff8db
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP2 SOX17 WWTR1 NFATC2 AHNAK2 PDZD2	1.12e-05	187	119	6	37d8ee5c8bd6324749e5a2adef1d0482c75da80c
ToppCell	3'-Adult-Appendix-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP2 SOX17 WWTR1 NFATC2 AHNAK2 PDZD2	1.12e-05	187	119	6	ec98d5e480b08854dfd0ba6b1dc6610455f90640
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DLGAP2 PRTG RAPH1 RTTN MYO1B CRACD	1.12e-05	187	119	6	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 MAP2 MYO1B DST SHANK2	1.12e-05	187	119	6	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAPH1 ACE CRACD PTPRM SLC12A7 DOP1B	1.12e-05	187	119	6	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAPH1 ACE CRACD PTPRM SLC12A7 DOP1B	1.12e-05	187	119	6	033ba52c0c2f9978784947098fa697368ae44834
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 MAP2 MYO1B SHANK2 GLS	1.15e-05	188	119	6	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTTNBP2 SOX17 F5 HMCN1 AKR1B10 AKR1B1	1.19e-05	189	119	6	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTTNBP2 SOX17 F5 CRACD HMCN1 AKR1B10	1.19e-05	189	119	6	b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCell	moderate-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PRTG COL12A1 AKAP12 EDNRB DST AEBP1	1.19e-05	189	119	6	22a19365782003c18ec8dddcdbfdaa82c4e330f6
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MMS22L RTTN E2F2 CDCA5 PLK4 ZNF730	1.22e-05	190	119	6	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	LIMA1 MYO1B CRACD DST KLHDC8A PDZRN3	1.22e-05	190	119	6	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	AKAP12 IGSF10 FNDC1 HMCN1 AEBP1 PDZRN3	1.26e-05	191	119	6	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 AKAP12 EDNRB CRACD NFATC2 AEBP1	1.26e-05	191	119	6	1caf726bd07fdca389e678fc16304a6ef1790423
ToppCell	metastatic_Lymph_Node-Fibroblasts-Myofibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	MXRA5 COL12A1 FNDC1 HMCN1 AEBP1 PDZRN3	1.26e-05	191	119	6	aa43b472bc8362f79ae63f09f1ca764718bbf22c
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	AKAP12 IGSF10 FNDC1 HMCN1 AEBP1 PDZRN3	1.26e-05	191	119	6	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 AKAP12 EDNRB CRACD NFATC2 AEBP1	1.26e-05	191	119	6	3d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACE AKAP12 FNDC1 AEBP1 IGSF1 CMAHP	1.30e-05	192	119	6	30cefa0990ba1f379f350bfbf994a78db145075e
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	MAP2 AKAP12 EDNRB ITPKB NFATC1 PDZD2	1.30e-05	192	119	6	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MXRA5 AKAP12 IGDCC4 IGSF10 AEBP1 PDZRN3	1.30e-05	192	119	6	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 AKAP12 EDNRB CRACD NFATC2 AEBP1	1.30e-05	192	119	6	9333aba0d04203ccccad78d82bf6359922f810a7
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	LIMA1 COL12A1 WWTR1 EDNRB NFATC2 PDZRN3	1.34e-05	193	119	6	e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MMS22L E2F2 IGSF1 CDCA5 PLK4 ZNF730	1.34e-05	193	119	6	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	INPP5D WWTR1 ACE ITPKB HMCN1 PTPRM	1.34e-05	193	119	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	COL12A1 CRACD DST HMCN1 AEBP1 PDZRN3	1.34e-05	193	119	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MXRA5 AKAP12 IGDCC4 IGSF10 AEBP1 PDZRN3	1.34e-05	193	119	6	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	LIMA1 COL12A1 WWTR1 EDNRB NFATC2 PDZRN3	1.34e-05	193	119	6	b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	EVC2 AKAP12 FNDC1 HMCN1 PTPRM AEBP1	1.34e-05	193	119	6	194e7fa00a50cc4e026987b715323d125d79594e
Drug	2-carboxybenzaldehyde	CTTNBP2 AKR1B10 AKR1B1 TPH1	5.82e-06	23	119	4	CID000008406
Drug	AL3152	INTU AKR1B10 AKR1B1	1.14e-05	9	119	3	CID000159501
Drug	lewisite	NCOA6 INPP5D DST	2.23e-05	11	119	3	CID005372798
Drug	4-oxoretinaldehyde	AKR1B10 AKR1B1	2.71e-05	2	119	2	ctd:C099660
Drug	propioin	AKR1B10 AKR1B1	2.71e-05	2	119	2	ctd:C523189
Drug	dehydroretinal	AKR1B10 AKR1B1	2.71e-05	2	119	2	ctd:C017184
Drug	Pentanones	AKR1B10 AKR1B1	2.71e-05	2	119	2	ctd:D010422
Drug	4-hydroxyretinal	AKR1B10 AKR1B1	2.71e-05	2	119	2	ctd:C057180
Drug	semduramicin	NCOA6 SHANK2	2.71e-05	2	119	2	CID000071327
Drug	AC1MRDQ4	CTTNBP2 AKR1B10 AKR1B1	2.96e-05	12	119	3	CID003491289
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	PLAC1 LIMA1 MAP2 TEX14 AKAP12 RAI2 AHNAK2	3.42e-05	172	119	7	3979_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	PLAC1 LIMA1 AKAP12 CAPRIN2 SCAPER RAI2 AHNAK2	3.55e-05	173	119	7	5308_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	LIMA1 MAP2 TEX14 AKAP12 GLS RAI2 AHNAK2	3.55e-05	173	119	7	4112_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	PLAC1 LIMA1 AKAP12 GLS SCAPER RAI2 AHNAK2	3.96e-05	176	119	7	6972_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	LIMA1 TEX14 AKAP12 GLS SCAPER RAI2 AHNAK2	4.11e-05	177	119	7	4821_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	PLAC1 LIMA1 MAP2 AKAP12 GLS RAI2 AHNAK2	4.26e-05	178	119	7	4388_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	LIMA1 MAP2 AKAP12 SCAPER DZIP3 RAI2 AHNAK2	4.57e-05	180	119	7	7407_UP
Drug	1-aminocyclopropanol	AKR1B10 AKR1B1 TPH1	4.86e-05	14	119	3	CID000148676
Drug	butylurethane	NCOA6 SHANK2 TPH1	4.86e-05	14	119	3	CID000011577
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	LIMA1 MAP2 TEX14 AKAP12 GLS RAI2 AHNAK2	5.07e-05	183	119	7	6434_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	MAP2 TEX14 F5 GLS CARF SCAPER PKN2	5.07e-05	183	119	7	5599_UP
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A	PLAC1 ERBB2 MYO7A ITPKB GLS PDZRN3 KDM4B	7.33e-05	194	119	7	2221_DN
Drug	Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	DSCAM PAK6 KLHDC8A CARF RAI2 AHNAK2 DOP1B	7.57e-05	195	119	7	5665_UP
Drug	Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A	ERBB2 ATXN7L1 F5 NFATC1 ZMIZ2 SCAPER AHNAK2	7.82e-05	196	119	7	4372_UP
Drug	2,4-hexadienal	AKR1B10 AKR1B1	8.10e-05	3	119	2	ctd:C079389
Drug	Acetoin	AKR1B10 AKR1B1	8.10e-05	3	119	2	ctd:D000093
Drug	aurantio-obtusin	ACE AKR1B1	8.10e-05	3	119	2	CID000155011
Drug	2,3-butylene glycol	AKR1B10 AKR1B1	8.10e-05	3	119	2	ctd:C026978
Drug	Lumicolchicine gamma [6901-14-0]; Up 200; 10uM; PC3; HT_HG-U133A	KLHL1 MYO1B TEX14 NEO1 ZMIZ2 SCAPER ULBP1	8.33e-05	198	119	7	4195_UP
Drug	fluphenazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	PLAC1 ERBB2 MAP2 MYO1B F5 INKA2 KDM4B	8.33e-05	198	119	7	6196_UP
Drug	nitrendipine; Down 200; 10uM; MCF7; HG-U133A	MYO7A CEP290 F5 AKAP12 AEBP1 PLK4 KDM4B	8.33e-05	198	119	7	336_DN
Drug	pyrachlostrobin	INTU LIMA1 COL12A1 FGFRL1 WWTR1 F5 INKA2 AKAP12 IGDCC4 NFATC1 AEBP1 KLHDC8A SLC12A7 PNOC	8.78e-05	811	119	14	ctd:C513428
Drug	Tetrandrine [518-34-3]; Up 200; 6.4uM; HL60; HT_HG-U133A	MYO1B SHANK2 NFATC1 ZMIZ2 DZIP3 SLC12A7 PLK4	8.87e-05	200	119	7	2520_UP
Drug	16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione	MAP2 CAPRIN2 CDCA5 AHNAK2	8.96e-05	45	119	4	ctd:C020175
Drug	geldanamycin	ERBB2 LIMA1 COL12A1 RTTN ATP13A5 DST RESF1 GLS OTUD4	1.47e-04	371	119	9	ctd:C001277
Drug	5-Isothiocyanatoalrestatin	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID000124861
Drug	M7HEQ	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID006452329
Drug	NAP-HEX-Q	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID005487149
Drug	WF-2421	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID000195567
Drug	4-chloro-3-hydroxybutanoate	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID010129995
Drug	matteuorienate A	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID000190958
Drug	5-azidoalrestatin	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID000128442
Drug	5-(3-Thienyl)tetrazol-1-yl)acetic acid	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID003035658
Drug	FR-62765	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID000128354
Drug	2,5-DHBQOP	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID000069213
Drug	danshenol B	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID003083515
Drug	iodomethanesulfonamide	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID000519939
Drug	nonadienal	NCOA6 AKR1B1	1.61e-04	4	119	2	CID000023203
Drug	salviaflaside	AKR1B10 AKR1B1	1.61e-04	4	119	2	CID006438919
Drug	dimethyl phosphite	ERVK-6 DST	1.61e-04	4	119	2	CID006327114
Disease	Colorectal Carcinoma	EVC2 SALL3 MAP2 FRMPD2 SOX17 MYO1B PAK6 ERI2 LRRC4 CSMD3 F5 AKAP12 NFATC1 AKR1B10 PAN2 ADAMTS18	2.78e-08	702	120	16	C0009402
Disease	meningitis	RAPH1 ITPKB SCAPER	1.06e-05	11	120	3	MONDO_0021108
Disease	Pulmonary Hypertension	ACE EDNRB NFATC2 TPH1	2.12e-05	40	120	4	C0020542
Disease	chronic kidney disease	DLGAP2 DSCAM ATXN7L1 NPHP4 NFATC1 PTPRM PDZRN3	5.15e-05	235	120	7	EFO_0003884
Disease	aldose reductase measurement	AKR1B10 AKR1B1	9.79e-05	4	120	2	EFO_0801364
Disease	juvenile-onset Parkinson's disease (implicated_via_orthology)	ATP13A4 ATP13A5	9.79e-05	4	120	2	DOID:0060893 (implicated_via_orthology)
Disease	Kufor-Rakeb syndrome (implicated_via_orthology)	ATP13A4 ATP13A5	9.79e-05	4	120	2	DOID:0060556 (implicated_via_orthology)
Disease	non-arteritic anterior ischemic optic neuropathy (is_implicated_in)	ACE F5	1.63e-04	5	120	2	DOID:0050864 (is_implicated_in)
Disease	mean corpuscular hemoglobin concentration	INTU RTTN SIGLEC5 E2F2 MYO1B IGDCC4 NEO1 PCIF1 OTUD4 PKN2 CMAHP SLC12A7 PLK4 PPP6R3	1.64e-04	1105	120	14	EFO_0004528
Disease	joint hypermobility measurement	PRTG COL12A1 FNDC1	3.27e-04	33	120	3	EFO_0007905
Disease	Senior-Loken syndrome (is_implicated_in)	CEP290 NPHP4	3.40e-04	7	120	2	DOID:0050576 (is_implicated_in)
Disease	Renal dysplasia and retinal aplasia	CEP290 NPHP4	3.40e-04	7	120	2	cv:C0403553
Disease	Hodgkins lymphoma	ATP13A5 ERI2 ACE SHANK2	3.56e-04	82	120	4	EFO_0000183
Disease	breast cancer (is_implicated_in)	NCOA6 PPM1D ACE F5 KDM4B	3.78e-04	150	120	5	DOID:1612 (is_implicated_in)
Disease	nephronophthisis (implicated_via_orthology)	WWTR1 NPHP4	5.80e-04	9	120	2	DOID:12712 (implicated_via_orthology)
Disease	white matter growth measurement	AKR1B10 AKR1B1	5.80e-04	9	120	2	EFO_0009335
Disease	ciliopathy (implicated_via_orthology)	CEP290 NPHP4 PLK4	5.81e-04	40	120	3	DOID:0060340 (implicated_via_orthology)
Disease	Alzheimer disease, polygenic risk score	MMS22L INPP5D ACE ITPKB DST RESF1 SCAPER HYDIN KDM4B	6.71e-04	586	120	9	EFO_0030082, MONDO_0004975
Disease	alopecia areata (is_marker_for)	KDM1A KDM4B	7.23e-04	10	120	2	DOID:986 (is_marker_for)
Disease	schizophrenia (is_marker_for)	MAP2 ARPC1A ACE	7.69e-04	44	120	3	DOID:5419 (is_marker_for)
Disease	carbohydrate measurement	PTPRM FUT3 KDM1A	8.76e-04	46	120	3	EFO_0004998
Disease	nucleus accumbens volume change measurement	DSCAM MUC16	8.81e-04	11	120	2	EFO_0021493
Disease	interleukin-6 measurement, response to stimulus	MUC16 CMAHP	8.81e-04	11	120	2	EFO_0004810, GO_0050896
Disease	prostate specific antigen measurement	PLAC1 SALL3 INKA2 ADAMTS18 RAI2	1.05e-03	188	120	5	EFO_0004624
Disease	Renal dysplasia and retinal aplasia (disorder)	CEP290 NPHP4	1.05e-03	12	120	2	C0403553
Disease	Hirschsprung's disease (implicated_via_orthology)	ERBB2 EDNRB	1.05e-03	12	120	2	DOID:10487 (implicated_via_orthology)
Disease	estradiol measurement	INTU DSCAM SHANK2 AKR1B1	1.08e-03	110	120	4	EFO_0004697
Disease	Ciliopathies	EVC2 MYO7A CEP290 NPHP4	1.08e-03	110	120	4	C4277690
Disease	diabetic retinopathy (is_implicated_in)	ACE SGF29 AKR1B1	1.12e-03	50	120	3	DOID:8947 (is_implicated_in)
Disease	coronary artery disease	NCOA6 DSCAM ZNF268 INPP5D AKAP12 IGSF10 CRACD FNDC1 GLS CARF PAN2 PKN2 KDM4B	1.16e-03	1194	120	13	EFO_0001645
Disease	serum gamma-glutamyl transferase measurement	E2F2 MYO1B CSMD3 RMI1 GPBP1L1 PTPRM ZMIZ2 PCIF1 PKN2 FUT3 KDM1A	1.28e-03	914	120	11	EFO_0004532
Disease	body mass index, osteoarthritis	RAPH1 PTPRM CARF	1.40e-03	54	120	3	EFO_0004340, MONDO_0005178
Disease	neuronal ceroid lipofuscinosis (implicated_via_orthology)	ATP13A4 ATP13A5	1.45e-03	14	120	2	DOID:14503 (implicated_via_orthology)
Disease	vascular endothelial growth factor measurement	ATP13A4 EVC2 ATP13A5	1.55e-03	56	120	3	EFO_0004762
Disease	Down syndrome (implicated_via_orthology)	DSCAM DOP1B	1.66e-03	15	120	2	DOID:14250 (implicated_via_orthology)
Disease	Calcium channel blocker use measurement	ARPC1A ACE NFATC2 AKR1B10 AKR1B1	1.82e-03	213	120	5	EFO_0009930
Disease	coronary thrombosis, GM11992	DSCAM SCAPER	1.90e-03	16	120	2	EFO_0001124, EFO_1000883
Disease	carcinoma (implicated_via_orthology)	ERBB2 SALL3 WWTR1	2.28e-03	64	120	3	DOID:305 (implicated_via_orthology)
Disease	adenosine monophosphate measurement	MYO1B CSMD3	2.40e-03	18	120	2	EFO_0010454
Disease	stem Cell Factor measurement	F5 PCIF1 AHNAK2	2.60e-03	67	120	3	EFO_0008291
Disease	hydrocephalus (implicated_via_orthology)	L1CAM HYDIN	2.68e-03	19	120	2	DOID:10908 (implicated_via_orthology)
Disease	diet measurement, body mass index	ATP13A4 ATP13A5	2.97e-03	20	120	2	EFO_0004340, EFO_0008111
Disease	coagulation factor V measurement	PAK6 F5	2.97e-03	20	120	2	EFO_0008087
Disease	stomach cancer (is_implicated_in)	ERBB2 ACE KDM4B	3.19e-03	72	120	3	DOID:10534 (is_implicated_in)
Disease	cortical surface area measurement	PRTG INTU CTTNBP2 RAPH1 MAP2 FGFRL1 NEO1 GLS ADAMTS18 PKN2 PDZRN3 KDM1A PDZD2	3.30e-03	1345	120	13	EFO_0010736
Disease	pentachlorophenol measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022071
Disease	parathion measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022070
Disease	potassium chromate measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022072
Disease	mercuric chloride measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022068
Disease	heptachlor epoxide measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022067
Disease	methoxychlor measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022052
Disease	azinphos methyl measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022055
Disease	aldrin measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022054
Disease	dicofol measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022060
Disease	disulfoton measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022062
Disease	dieldrin measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022061
Disease	endrin measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022064
Disease	endosulfan measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022063
Disease	heptachlor measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022066
Disease	ethion measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022065
Disease	chlorpyrifos measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022057
Disease	cadmium chloride measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022056
Disease	diazinon measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022059
Disease	dibutyl phthalate measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0022058
Disease	environmental exposure measurement	DLGAP2 MUC16 F5	3.32e-03	73	120	3	EFO_0008360
Disease	obsolete_red blood cell distribution width	ARPC1A E2F2 HSD11B1L LIN52 NEO1 RESF1 PCIF1 SCAPER PKN2 FUT3 SLC12A7 CDCA5 PPP6R3	3.34e-03	1347	120	13	EFO_0005192
Disease	DDT metabolite measurement	DLGAP2 MUC16 F5	3.45e-03	74	120	3	EFO_0007886
Disease	melanoma	MYO7A MYO1B AKR1B10 KDM1A KDM4B	3.51e-03	248	120	5	C0025202
Disease	myeloperoxidase (MPO)-DNA complex measurement	ATP13A4 ATP13A5	3.59e-03	22	120	2	EFO_0011039
Disease	Primary microcephaly	RTTN PLK4	3.59e-03	22	120	2	C0431350
Disease	Non-Small Cell Lung Carcinoma	ERBB2 MXRA5 E2F2 KDM1A	3.84e-03	156	120	4	C0007131
Disease	Carcinoma of lung	ERBB2 MXRA5	3.92e-03	23	120	2	C0684249
Disease	total iron binding capacity	F5 GPBP1L1 CMAHP	4.00e-03	78	120	3	EFO_0006334
Disease	gut microbiome measurement, bone density	COL12A1 PTPRM NFATC2	4.00e-03	78	120	3	EFO_0003923, EFO_0007874

Protein segments in the cluster

Peptide	Gene	Start	Entry
APSSPGSSWMKKDQP	AKIRIN1	116	Q9H9L7
VNLQEPWKSGKMTPP	ERI2	581	A8K979
QMKLPSTKKAEPPTW	ERVK-25	36	P61579
PSGVKPDLSYMPIWK	ERBB2	601	P04626
AKPWAPDMTLPGISP	CDCA5	196	Q96FF9
TKTPLPQMENTMPWK	ATP13A5	321	Q4VNC0
QMKLPSTKKAEPPTW	ERVK-19	36	O71037
QMKLPSTKKAEPPTW	ERVK-8	36	Q902F8
QMKLPSTKKAEPPTW	ERVK-9	36	Q9UKH3
WLSGMNIPPPIISNK	CSMD3	306	Q7Z407
VPPEFWNKSMLEKPT	ACE	936	P12821
GVTPWASFKKMVTPK	AKAP12	606	Q02952
EWTPTEKVKCPPIGM	AEBP1	376	Q8IUX7
TKTPLPKMDSSVPWK	ATP13A4	321	Q4VNC1
SLYGPWMPSSLGKPK	GRM4	21	Q14833
AKMPIVGLGTWKSPL	AKR1B10	11	O60218
TKPQKDDPGTMPWVK	AGGF1	696	Q8N302
ERKPEGKPRPGMSSW	DLGAP2	281	Q9P1A6
QTAEIMTPPTKTLWP	EDNRB	41	P24530
MTPPTKTLWPKGSNA	EDNRB	46	P24530
KPPPPELDMAIKWSN	C1orf52	116	Q8N6N3
TLTETPLRGWPQPKM	HSD11B1L	256	Q7Z5J1
NSQMWKKIPPAADSP	ATXN7L1	501	Q9ULK2
WKYALPKVMNGTPPA	ADAMTS18	856	Q8TE60
AKMPILGLGTWKSPP	AKR1B1	11	P15121
VDEKPASTPWGSKMP	ARPC1A	176	Q92747
WKGKTEKAPAPDMPI	IGDCC4	731	Q8TDY8
MKSVPWLKAGEVSPP	RAI2	321	Q9Y5P3
QMKLPSTKKAEPPTW	HERVK_113	36	P61574
QMKLPSTKKAEPPTW	ERVK-19	36	P61572
MKLPSTKKAEPPTWA	ERVK-21	36	P61571
QMKLPSTKKAEPPTW	ERVK-6	36	Q69383
QMKLPSTKKAEPPTW	ERVK-9	36	P61573
SPTPSEPRMEWKVKI	PDZRN3	911	Q9UPQ7
WSKMSVKKAPPPTRP	RAPH1	1111	Q70E73
APPPESWNTVSGKKM	OTUD4	331	Q01804
WSPPLDKMGNSVKGI	GLS	501	O94925
PLKEASWKPVAPMLK	KLHL30	351	Q0D2K2
MNKDPEILSWTIPPS	MUC16	6781	Q8WXI7
ATDSPCGIPPKMWKT	NFATC2	311	Q13469
CGIPPKMWKTSPDPS	NFATC2	316	Q13469
KMWKTSPDPSPVSAA	NFATC2	321	Q13469
KMDWKVPEPEGQTSP	PAN2	1176	Q504Q3
PKRKSLVGTPYWMAP	PAK6	556	Q9NQU5
KTMDPSCLKWTPPKG	KAT7	596	O95251
PENGWSKLTEMPAKS	KLHL31	341	Q9H511
FKSPITSSPPKWMAE	LIN52	46	Q52LA3
MSKPKWPPEDEISKP	LIMA1	551	Q9UHB6
KTVSPPIRKGWSMSE	LIMA1	606	Q9UHB6
LKEKPGWVTPMVPES	INKA2	226	Q9NTI7
MGPEAWVRPLKTAPK	ERVS71-1	1	P61550
GVWENPPSAKQPSKM	GPBP1L1	181	Q9HC44
SWLPFKGLANTMKSP	MMS22L	441	Q6ZRQ5
KWKVISPTGNEAMVP	DST	921	Q03001
MSSLSPGKPWQTKLS	MYG1	116	Q9HB07
SWEPKPITVPQFKQM	DOP1B	681	Q9Y3R5
PSPAKPATRLMWKSQ	CARF	251	Q8N187
DPPPLTMWTKDGRTI	FGFRL1	56	Q8N441
LTSPKPVPEQGMWSR	PDZD2	1986	O15018
TPMAQRKLPPSFWKE	PERCC1	206	A0A1W2PR82
WAKPKPLSPTSYMSP	NFATC1	396	O95644
QKGPTWKEPVSPMEL	KDM4B	556	O94953
PESSTQDLPCMIWPK	EVC2	71	Q86UK5
TPPMSSVKWLLPNGT	LRRC4	376	Q9HBW1
MAEGAPKWPKETVKP	L1CAM	131	P32004
GPKESLPVIAAPSMW	ACBD3	361	Q9H3P7
KLAEWPKTMTGLPST	PPM1D	156	O15297
PAPKKGWNMEPPSSD	DZIP3	481	Q86Y13
KGMDAVSPWKSSAVP	NPHP4	1086	O75161
KVFPSPLWTPCTKVM	PNOC	51	Q13519
MECKTSGIPPPQVKW	HMCN1	721	Q96RW7
SPPPTIMWLKDGQLI	HMCN1	1761	Q96RW7
PPTVTWMKDGHPLIK	HMCN1	2321	Q96RW7
EGIPSPKMSWLKNGR	PRTG	351	Q2VWP7
SPGNWTDQKKAPPVM	INTU	886	Q9ULD6
GTMTANQGWKKAPLP	NCOA6	336	Q14686
TGEPKPQIMWRLPSK	IGSF10	1966	Q6WRI0
SDGIPKPNIKWTMPS	IGSF10	2456	Q6WRI0
PKPSLSAWPSTMFKL	IGSF1	1161	Q8N6C5
KKSLWTIEPNEGMVP	HYDIN	846	Q4G0P3
PPLPEWKTSAVQRMG	KDM1A	641	O60341
SIPGTPTLKMWGTSP	PCIF1	146	Q9H4Z3
PTLKMWGTSPEDKQQ	PCIF1	151	Q9H4Z3
PKVVPAMSPTELWPS	E2F2	16	Q14209
SKPPPQITWLLGNSM	CRTAM	146	O95727
TMRVTWKPAPGKVVN	COL12A1	1011	Q99715
QMKLPSTKKAEPPTW	ERVK-25	36	P61570
QMKLPSTKKAEPPTW	ERVK-6	36	Q69384
QTAWDLMKQSPTPVP	CEP290	1601	O15078
LPTWNKPDLSTEGMK	CTTNBP2	1471	Q8WZ74
IQKPMTWDSLSGPPV	FRMPD2	736	Q68DX3
TKMGLKVTWDPPKDA	FNDC1	51	Q4ZHG4
KTPPVNAKFSIMPAW	CRACD	711	Q6ZU35
DPKKQTPKSWTPSMQ	CAPRIN2	506	Q6IMN6
MKLPSTKKAEPPTWA	ERVK-21	36	P61565
PGKNKWEILPAMPTP	KLHDC8A	301	Q8IYD2
QMKLPSTKKAEPPTW	HERVK_113	36	Q902F9
TTIIPLNWMLKSPPG	nan	21	Q6ZN92
PPTPDKVQMTWTREK	SLC12A7	971	Q9Y666
PTSLAWEVKKMSPGR	SCAPER	166	Q9BY12
MSLPPEKPVTTWLDS	SALL3	501	Q9BXA9
VNTLTKPTSDPWMPS	PTPRM	51	P28827
MPPLWGSQIFTKPSS	ODF3L2	166	Q3SX64
VKTKVPWMPPGKSSA	ODF2	61	Q5BJF6
APPVLKMWKLVHTTP	MROH2A	1266	A6NES4
PFPEITKMLGAEWSK	HMG20B	96	Q9P0W2
PCKAVGDPSPAVKWM	DSCAM	1306	O60469
WDIMSNPKSRLPPSP	FUT3	111	P21217
AAPQKSPWLTKPCSM	PLAC1	116	Q9HBJ0
MWSVNPSNKPSLPSV	RTTN	961	Q86VV8
PWAESLSPIGDMKVK	SOX17	31	Q9H6I2
MAKKAATGQLTVPPW	TEX14	941	Q8IWB6
VWPLLPGSFKTLEMK	F5	1861	P12259
QVTPKPWEAKPSRML	RMI1	121	Q9H9A7
MNWNEKPKSATLPPL	RESF1	1	Q9HCM1
AKVWMIDFGKTTPLP	ITPKB	891	P27987
PAKPGSSWIPFKEIM	SMG1	2061	Q96Q15
VASGLPTPTIKWMKN	NEO1	271	Q92859
GKPTPTVKWVKNGDM	NEO1	366	Q92859
ATALMLPVKPPAGSW	PRSS57	16	Q6UWY2
SGIPLNMAPKKWTRG	POLR3A	326	O14802
WNMGNAPPPKKITSW	INPP5D	411	Q92835
PIMGTITSGSRKKPW	SIGLEC5	481	O15389
IFWGPPSKMQKPQGS	ST6GALNAC6	181	Q969X2
WSALMDKKVKPPFIP	PKN2	921	Q16513
PLSEQSKTRGMEPPW	PLK4	566	O00444
PGMAKVLQPRTSKLW	SHANK2	1591	Q9UPX8
RMPKFKIPSLGWSPS	AHNAK2	581	Q8IVF2
IKLPLTPPNWKSFLM	CMAHP	456	Q9Y471
GMETVPWFPKKISDL	TPH1	101	P17752
QPKITKSWGPLSFMD	ZNF268	71	Q14587
MSCVKLWPSGAPAPL	RIPK3	1	Q9Y572
SAMTLPLWIGKPGDK	SGF29	126	Q96ES7
WKLGMSETRAKPEPP	SOGA1	1271	O94964
QMKLPSTKKAEPPTW	ERVK-8	36	P61575
IPKWEGKQFDSPMPS	MAP2	301	P11137
PMPWDLSNKAVPEPK	NEURL3	181	Q96EH8
EPWNLKTHDMVAKPP	ZNF730	61	Q6ZMV8
PTCSWKPVPVKPDMH	ZMIZ2	676	Q8NF64
WEQMLDPTKPPSLAP	ULBP1	201	Q9BZM6
KSVMKTTWGVLDPPV	PPP6R3	326	Q5H9R7
MNPKPSSWRKKILPE	WWTR1	36	Q9GZV5
YNPKTKTWTVLPPMS	KLHL1	526	Q9NR64
KNKMPSLSPIDKNWP	MYO1B	886	O43795
KGEPMPKVTWLSPTN	MXRA5	2371	Q9NR99
KLWTTTVPGKDPMAD	MYO7A	1996	Q13402